查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1140267

类器官和球体市场：按类型、方法和最终用户：2021-2031 年全球机会分析和行业预测

Organoids and Spheroids Market By Type, By Method, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 315 Pages | 商品交期: 2-3个工作天内

价格

全球类器官和球体市场2021年将达到5.1656亿美元，2031年达到117.996万美元，2022年至2031年復合年增长率为8.5% 预计

类器官是在基于支架的系统上最常生长的 3D 细胞培养物。类器官通常由单个成人或胚胎干细胞製成。它们也可以由诱导多能干细胞製成，例如皮肤或血细胞。球体是在无支架系统中生长的 3D 细胞培养物。球体由单细胞类型或多细胞混合细胞产生的细胞聚集体组成。球体可以从永生化细胞系、原代细胞和人体组织碎片中建立。

推动市场增长的主要因素是越来越多地采用个性化医疗、增加对研发活动的投资，以及对用于癌症研究的类器官 3D 细胞培养的偏好的改变。此外，製药和生物技术公司增加产品开发正在推动市场增长。例如，康宁公司推出了用于高通量培养的 HTS Transwell 组织培养系统和球体微孔板，以帮助组织生长，并为基于细胞的疗法和个性化药物的发展做出贡献。

但是，高昂的引入成本阻碍了市场增长。相反，预计发展中国家的技术进步和新兴医疗保健市场将在预测期内提供有利可图的机会。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概览

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特五力分析
  • 主要公司的定位
  • 市场动态
    • 驱动程序
    • 约束因素
    • 机会
  • COVID-19 影响分析

第 4 章类器官和球体市场：按类型分类

  • 概览
    • 市场规模和预测
  • 类器官
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
    • 类器官类器官和球状体市场：按类型
  • 球体
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
    • 类球体和类球体市场：按类型

第 5 章类器官和球体市场：按方法分类

  • 概览
    • 市场规模和预测
  • 细胞外基质支架法
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 纺纱法
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 悬滴法
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 低粘附培养板法
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 磁悬浮法
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 6 章类器官和球体市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 生物技术、製药行业
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 学术和研究机构
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 医院和诊断中心
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 7 章。类器官和球体市场：按地区划分

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机遇
    • 北美市场规模和预测：按类型
    • 北美市场规模和预测：按方法分类
    • 北美市场规模和预测：按最终用户分类
    • 北美市场规模和预测：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 主要趋势和机遇
    • 欧洲市场规模和预测：按类型
    • 欧洲市场规模和预测：按方法分类
    • 欧洲市场规模和预测：按最终用户分类
    • 欧洲市场规模和预测：按国家/地区分类
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 其他欧洲
  • 亚太地区
    • 主要趋势和机遇
    • 亚太市场规模和预测：按类型
    • 亚太市场规模和预测：按方法分类
    • 亚太市场规模和预测：按最终用户分类
    • 亚太地区的市场规模和预测：按国家/地区分类
      • 日本
      • 中国
      • 澳大利亚
      • 印度
      • 韩国
      • 其他亚太地区
  • LAMEA
    • 主要趋势和机遇
    • LAMEA 市场规模和预测：按类型
    • LAMEA 市场规模和预测：按方法分类
    • LAMEA 市场规模和预测：按最终用户分类
    • LAMEA 市场规模和预测：按国家/地区分类
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其余部分

第八章企业情况

  • 简介
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 竞赛仪表板
  • 比赛热图
  • 主要发展

第 9 章公司简介

  • ATCC
  • 3D Biotek LLC
  • 3Dnamics Inc
  • Cellesce Ltd
  • Corning Inc
  • DefiniGEN Ltd
  • Greiner AG
  • Hubrecht Organoid Technology
  • InSphero AG
  • Lonza
  • Merck KGaA
  • PeproTech Inc.
  • Perkin Elmer Inc
  • Prellis Biologics
  • STEMCELL Technologies Inc
  • Thermofisher Scientific Inc
Product Code: A17036

The global organoids and spheroids market was valued at $516.56 million in 2021 and is projected to reach $1,179.96 million by 2031, registering a CAGR of 8.5% from 2022 to 2031. Organoids are 3D cell cultures most frequently grown on a scaffold-based system. Organoids are normally derived from a single adult stem cell or embryonic stem cell. They can also be produced from induced pluripotent stem cells such as skin or blood cells. Spheroids are 3D cell cultures that are grown on a scaffold-free system. They consist of cell aggregates generated from a single cell type or from a multicellular mixture of cells. Spheroids can be established from immortalized cell lines, primary cells, or fragments of human tissue.

The key factors that drive the growth of the market are an increase in the adoption of personalized medicines, growth in investments toward R&D activities and a shift in preference toward organoids 3D cell cultures for cancer research are the major factors that boost the growth of the organoids and spheroids market. Moreover, an increase in product development by pharma & biotech companies propels the growth of the market. For instance, Corning Incorporated launched HTS Transwell tissue culture systems and spheroid microplates for high-throughput culturing, which will help in cell tissue culturing and help in the development of cell-based therapies or personalized medicines. 

However, higher implementation cost hampers the market growth. Conversely, technological advancements and emerging healthcare market in developing countries is expected to provide a lucrative opportunity during the forecast period. 

The organoids and spheroid market are segmented on the basis of type, method, end user, and region. By type, it is segmented into organoids and spheroids. On the basis of method, it is segmented into extracellular matrix scaffold method, spinning bioreactor method, hanging drop method, low adherent culture plate method, magnetic levitation method, and others. By end user, it is segmented into biotechnology and pharmaceutical industries, academic & research institutes, hospitals, and diagnostic centers. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the organoids and spheroid market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the increase in the healthcare expenditure of this region and the presence of significant players in the country and the strategies they adopt for their product development.

Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register the fastest CAGR during the forecast period, owing to a rise in the prevalence of cancer and an increase in demand of cell tissue culturing techniques.

The key players that operate in the organoids and spheroid market are AMS Biotechnology Limited, ATCC, 3D Biotek LLC, 3Dnamics Inc., Cellesce Ltd., Corning Inc, DefiniGEN Ltd, Greiner AG, Hubrecht Organoid Technology, InSphero AG, Lonza, Merck KGaA, PeproTech Inc., Perkin Elmer Inc, Prellis Biologics, STEMCELL Technologies Inc. and Thermofisher Scientific Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the organoids and spheroids market analysis from 2021 to 2031 to identify the prevailing organoids and spheroids market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the organoids and spheroids market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global organoids and spheroids market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Organoids
    • Type
    • Neural Organoids
    • Hepatic Organoids
    • Intestinal Organoids
    • Others
  • Spheroids
    • Type
    • Multicellular Tumor spheroids
    • Neurospheres
    • Mammospheres
    • Hepatospheres 

By Method

  • Others
  • Extracellular Matrix scaffold Method
  • Spinning Boireactor method
  • Hanging Drop method
  • Low adherent Culture plate method
  • Magnetic leviation Method

By End User

  • Biotechnology and Pharmaceutical Industry
  • Academic and Research Institutes
  • Hospitals and Diagnostic Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • ATCC
    • 3D Biotek LLC
    • 3Dnamics Inc
    • Cellesce Ltd
    • Corning Inc
    • DefiniGEN Ltd
    • Greiner AG
    • Hubrecht Organoid Technology
    • InSphero AG
    • Lonza
    • Merck KGaA
    • PeproTech Inc.
    • Perkin Elmer Inc
    • Prellis Biologics
    • STEMCELL Technologies Inc
    • Thermofisher Scientific Inc

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Organoids
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Organoids Organoids and Spheroids Market by Type
  • 4.3 Spheroids
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
    • 4.3.4 Spheroids Organoids and Spheroids Market by Type

CHAPTER 5: ORGANOIDS AND SPHEROIDS MARKET, BY METHOD

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Extracellular Matrix scaffold Method
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Spinning Boireactor method
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Hanging Drop method
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Low adherent Culture plate method
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country
  • 5.6 Magnetic leviation Method
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market analysis by country
  • 5.7 Others
    • 5.7.1 Key market trends, growth factors and opportunities
    • 5.7.2 Market size and forecast, by region
    • 5.7.3 Market analysis by country

CHAPTER 6: ORGANOIDS AND SPHEROIDS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Biotechnology and Pharmaceutical Industry
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Academic and Research Institutes
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Hospitals and Diagnostic Centers
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: ORGANOIDS AND SPHEROIDS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Method
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Method
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Method
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Method
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Method
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Method
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Method
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Method
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Method
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Method
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Method
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Method
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Method
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Method
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Method
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Method
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Method
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest Of Asia Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Method
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Method
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Method
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Method
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Method
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Method
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 ATCC
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 3D Biotek LLC
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 3Dnamics Inc
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Cellesce Ltd
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Corning Inc
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 DefiniGEN Ltd
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Greiner AG
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Hubrecht Organoid Technology
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 InSphero AG
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Lonza
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 Merck KGaA
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 PeproTech Inc.
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments
  • 9.13 Perkin Elmer Inc
    • 9.13.1 Company overview
    • 9.13.2 Company snapshot
    • 9.13.3 Operating business segments
    • 9.13.4 Product portfolio
    • 9.13.5 Business performance
    • 9.13.6 Key strategic moves and developments
  • 9.14 Prellis Biologics
    • 9.14.1 Company overview
    • 9.14.2 Company snapshot
    • 9.14.3 Operating business segments
    • 9.14.4 Product portfolio
    • 9.14.5 Business performance
    • 9.14.6 Key strategic moves and developments
  • 9.15 STEMCELL Technologies Inc
    • 9.15.1 Company overview
    • 9.15.2 Company snapshot
    • 9.15.3 Operating business segments
    • 9.15.4 Product portfolio
    • 9.15.5 Business performance
    • 9.15.6 Key strategic moves and developments
  • 9.16 Thermofisher Scientific Inc
    • 9.16.1 Company overview
    • 9.16.2 Company snapshot
    • 9.16.3 Operating business segments
    • 9.16.4 Product portfolio
    • 9.16.5 Business performance
    • 9.16.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR ORGANOIDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. ORGANOIDS AND SPHEROIDS MARKET FOR ORGANOIDS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL ORGANOIDS ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR SPHEROIDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. ORGANOIDS AND SPHEROIDS MARKET FOR SPHEROIDS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 7. GLOBAL SPHEROIDS ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 8. GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 9. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR EXTRACELLULAR MATRIX SCAFFOLD METHOD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. ORGANOIDS AND SPHEROIDS MARKET FOR EXTRACELLULAR MATRIX SCAFFOLD METHOD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR SPINNING BOIREACTOR METHOD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. ORGANOIDS AND SPHEROIDS MARKET FOR SPINNING BOIREACTOR METHOD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR HANGING DROP METHOD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. ORGANOIDS AND SPHEROIDS MARKET FOR HANGING DROP METHOD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR LOW ADHERENT CULTURE PLATE METHOD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. ORGANOIDS AND SPHEROIDS MARKET FOR LOW ADHERENT CULTURE PLATE METHOD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR MAGNETIC LEVIATION METHOD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. ORGANOIDS AND SPHEROIDS MARKET FOR MAGNETIC LEVIATION METHOD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. ORGANOIDS AND SPHEROIDS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 22. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. ORGANOIDS AND SPHEROIDS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 25. ORGANOIDS AND SPHEROIDS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 26. ORGANOIDS AND SPHEROIDS MARKET SIZE, FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 27. ORGANOIDS AND SPHEROIDS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 28. ORGANOIDS AND SPHEROIDS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 31. NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 33. U.S. ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 34. U.S. ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 35. U.S. ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. CANADA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 37. CANADA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 38. CANADA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. MEXICO ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 40. MEXICO ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 41. MEXICO ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. EUROPE ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 48. GERMANY ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. UK ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. UK ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 54. UK ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. ITALY ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. ITALY ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 57. ITALY ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 60. SPAIN ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. CHINA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 72. CHINA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 73. CHINA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. AUSTRALIA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 75. AUSTRALIA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 76. AUSTRALIA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. INDIA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. INDIA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 79. INDIA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. SOUTH KOREA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. SOUTH KOREA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 82. SOUTH KOREA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 87. LAMEA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 88. LAMEA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. LAMEA ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 90. BRAZIL ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 91. BRAZIL ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 92. BRAZIL ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. SAUDI ARABIA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 94. SAUDI ARABIA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 95. SAUDI ARABIA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96. SOUTH AFRICA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 97. SOUTH AFRICA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 98. SOUTH AFRICA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99. REST OF LAMEA ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 100. REST OF LAMEA ORGANOIDS AND SPHEROIDS MARKET, BY METHOD, 2021-2031 ($MILLION)
  • TABLE 101. REST OF LAMEA ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 102.ATCC: COMPANY SNAPSHOT
  • TABLE 103.ATCC: OPERATING SEGMENTS
  • TABLE 104.ATCC: PRODUCT PORTFOLIO
  • TABLE 105.ATCC: NET SALES,
  • TABLE 106.ATCC: KEY STRATERGIES
  • TABLE 107.3D BIOTEK LLC: COMPANY SNAPSHOT
  • TABLE 108.3D BIOTEK LLC: OPERATING SEGMENTS
  • TABLE 109.3D BIOTEK LLC: PRODUCT PORTFOLIO
  • TABLE 110.3D BIOTEK LLC: NET SALES,
  • TABLE 111.3D BIOTEK LLC: KEY STRATERGIES
  • TABLE 112.3DNAMICS INC: COMPANY SNAPSHOT
  • TABLE 113.3DNAMICS INC: OPERATING SEGMENTS
  • TABLE 114.3DNAMICS INC: PRODUCT PORTFOLIO
  • TABLE 115.3DNAMICS INC: NET SALES,
  • TABLE 116.3DNAMICS INC: KEY STRATERGIES
  • TABLE 117.CELLESCE LTD: COMPANY SNAPSHOT
  • TABLE 118.CELLESCE LTD: OPERATING SEGMENTS
  • TABLE 119.CELLESCE LTD: PRODUCT PORTFOLIO
  • TABLE 120.CELLESCE LTD: NET SALES,
  • TABLE 121.CELLESCE LTD: KEY STRATERGIES
  • TABLE 122.CORNING INC: COMPANY SNAPSHOT
  • TABLE 123.CORNING INC: OPERATING SEGMENTS
  • TABLE 124.CORNING INC: PRODUCT PORTFOLIO
  • TABLE 125.CORNING INC: NET SALES,
  • TABLE 126.CORNING INC: KEY STRATERGIES
  • TABLE 127.DEFINIGEN LTD: COMPANY SNAPSHOT
  • TABLE 128.DEFINIGEN LTD: OPERATING SEGMENTS
  • TABLE 129.DEFINIGEN LTD: PRODUCT PORTFOLIO
  • TABLE 130.DEFINIGEN LTD: NET SALES,
  • TABLE 131.DEFINIGEN LTD: KEY STRATERGIES
  • TABLE 132.GREINER AG: COMPANY SNAPSHOT
  • TABLE 133.GREINER AG: OPERATING SEGMENTS
  • TABLE 134.GREINER AG: PRODUCT PORTFOLIO
  • TABLE 135.GREINER AG: NET SALES,
  • TABLE 136.GREINER AG: KEY STRATERGIES
  • TABLE 137.HUBRECHT ORGANOID TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 138.HUBRECHT ORGANOID TECHNOLOGY: OPERATING SEGMENTS
  • TABLE 139.HUBRECHT ORGANOID TECHNOLOGY: PRODUCT PORTFOLIO
  • TABLE 140.HUBRECHT ORGANOID TECHNOLOGY: NET SALES,
  • TABLE 141.HUBRECHT ORGANOID TECHNOLOGY: KEY STRATERGIES
  • TABLE 142.INSPHERO AG: COMPANY SNAPSHOT
  • TABLE 143.INSPHERO AG: OPERATING SEGMENTS
  • TABLE 144.INSPHERO AG: PRODUCT PORTFOLIO
  • TABLE 145.INSPHERO AG: NET SALES,
  • TABLE 146.INSPHERO AG: KEY STRATERGIES
  • TABLE 147.LONZA: COMPANY SNAPSHOT
  • TABLE 148.LONZA: OPERATING SEGMENTS
  • TABLE 149.LONZA: PRODUCT PORTFOLIO
  • TABLE 150.LONZA: NET SALES,
  • TABLE 151.LONZA: KEY STRATERGIES
  • TABLE 152.MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 153.MERCK KGAA: OPERATING SEGMENTS
  • TABLE 154.MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 155.MERCK KGAA: NET SALES,
  • TABLE 156.MERCK KGAA: KEY STRATERGIES
  • TABLE 157.PEPROTECH INC.: COMPANY SNAPSHOT
  • TABLE 158.PEPROTECH INC.: OPERATING SEGMENTS
  • TABLE 159.PEPROTECH INC.: PRODUCT PORTFOLIO
  • TABLE 160.PEPROTECH INC.: NET SALES,
  • TABLE 161.PEPROTECH INC.: KEY STRATERGIES
  • TABLE 162.PERKIN ELMER INC: COMPANY SNAPSHOT
  • TABLE 163.PERKIN ELMER INC: OPERATING SEGMENTS
  • TABLE 164.PERKIN ELMER INC: PRODUCT PORTFOLIO
  • TABLE 165.PERKIN ELMER INC: NET SALES,
  • TABLE 166.PERKIN ELMER INC: KEY STRATERGIES
  • TABLE 167.PRELLIS BIOLOGICS: COMPANY SNAPSHOT
  • TABLE 168.PRELLIS BIOLOGICS: OPERATING SEGMENTS
  • TABLE 169.PRELLIS BIOLOGICS: PRODUCT PORTFOLIO
  • TABLE 170.PRELLIS BIOLOGICS: NET SALES,
  • TABLE 171.PRELLIS BIOLOGICS: KEY STRATERGIES
  • TABLE 172.STEMCELL TECHNOLOGIES INC: COMPANY SNAPSHOT
  • TABLE 173.STEMCELL TECHNOLOGIES INC: OPERATING SEGMENTS
  • TABLE 174.STEMCELL TECHNOLOGIES INC: PRODUCT PORTFOLIO
  • TABLE 175.STEMCELL TECHNOLOGIES INC: NET SALES,
  • TABLE 176.STEMCELL TECHNOLOGIES INC: KEY STRATERGIES
  • TABLE 177.THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT
  • TABLE 178.THERMOFISHER SCIENTIFIC INC: OPERATING SEGMENTS
  • TABLE 179.THERMOFISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
  • TABLE 180.THERMOFISHER SCIENTIFIC INC: NET SALES,
  • TABLE 181.THERMOFISHER SCIENTIFIC INC: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ORGANOIDS AND SPHEROIDS MARKET SEGMENTATION
  • FIGURE 2.ORGANOIDS AND SPHEROIDS MARKET,2021-2031
  • FIGURE 3.ORGANOIDS AND SPHEROIDS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ORGANOIDS AND SPHEROIDS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.ORGANOIDS AND SPHEROIDS MARKET,BY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ORGANOIDS ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SPHEROIDS ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 15.ORGANOIDS AND SPHEROIDS MARKET,BY METHOD,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF EXTRACELLULAR MATRIX SCAFFOLD METHOD ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPINNING BOIREACTOR METHOD ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HANGING DROP METHOD ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF LOW ADHERENT CULTURE PLATE METHOD ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MAGNETIC LEVIATION METHOD ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 22.ORGANOIDS AND SPHEROIDS MARKET,BY END USER,2021(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ACADEMIC AND RESEARCH INSTITUTES ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND DIAGNOSTIC CENTERS ORGANOIDS AND SPHEROIDS MARKET,2021-2031(%)
  • FIGURE 26.ORGANOIDS AND SPHEROIDS MARKET BY REGION,2021
  • FIGURE 27.U.S. ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 28.CANADA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 29.MEXICO ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 32.UK ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 33.ITALY ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 34.SPAIN ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 39.INDIA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 40.SOUTH KOREA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 42.BRAZIL ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 43.SAUDI ARABIA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH AFRICA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF LAMEA ORGANOIDS AND SPHEROIDS MARKET,2021-2031($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50.COMPETITIVE DASHBOARD
  • FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 52.ATCC.: NET SALES ,($MILLION)
  • FIGURE 53.3D BIOTEK LLC.: NET SALES ,($MILLION)
  • FIGURE 54.3DNAMICS INC.: NET SALES ,($MILLION)
  • FIGURE 55.CELLESCE LTD.: NET SALES ,($MILLION)
  • FIGURE 56.CORNING INC.: NET SALES ,($MILLION)
  • FIGURE 57.DEFINIGEN LTD.: NET SALES ,($MILLION)
  • FIGURE 58.GREINER AG.: NET SALES ,($MILLION)
  • FIGURE 59.HUBRECHT ORGANOID TECHNOLOGY.: NET SALES ,($MILLION)
  • FIGURE 60.INSPHERO AG.: NET SALES ,($MILLION)
  • FIGURE 61.LONZA.: NET SALES ,($MILLION)
  • FIGURE 62.MERCK KGAA.: NET SALES ,($MILLION)
  • FIGURE 63.PEPROTECH INC..: NET SALES ,($MILLION)
  • FIGURE 64.PERKIN ELMER INC.: NET SALES ,($MILLION)
  • FIGURE 65.PRELLIS BIOLOGICS.: NET SALES ,($MILLION)
  • FIGURE 66.STEMCELL TECHNOLOGIES INC.: NET SALES ,($MILLION)
  • FIGURE 67.THERMOFISHER SCIENTIFIC INC.: NET SALES ,($MILLION)